🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Kotak upgrades DLF stock to Buy with unchanged INR960 target

Published 28/10/2024, 13:04
DLF
-

On Monday, DLF Ltd. (DLFU:IN) received an upgrade in stock rating from an 'Add' to a 'Buy' by Kotak, with a maintained price target of INR960.00. Despite DLF's second quarter financial year 2025 (2QFY25) pre-sales being notably weak at Rs6.9 billion, which is considered one of the poorest performances in recent years, the company's management remains confident.

They attribute the poor performance to delays in approvals but maintain a pre-sales forecast of Rs170 billion for the fiscal year 2025 (FY2025), bolstered by Rs410 billion worth of new project launches.

DLF's management has highlighted the strong response to its upcoming super-luxury project, The Dahlias, which is expected to launch in the third quarter of FY2025 following the receipt of RERA approval. Additional launches in Mumbai, Goa, and a new phase of Privana are planned for the fourth quarter of FY2025.

DLF's commercial arm, DCCDL, reported a high occupancy rate of 93% and continues to show double-digit profit after tax (PAT) growth. The company is also set to commission incremental assets of 3.1 million square feet, 94% of which is already pre-leased, over the next 12 to 18 months.

The analyst acknowledged the disappointing pre-sales for the quarter but expressed belief in DLF's ability to leverage the housing demand through its robust pipeline of launches, which is valued at Rs635 billion beyond FY2025. This optimistic outlook on the company's future prospects and strong launch pipeline has led to the upgrade in the stock's rating to 'Buy', with the fair value (FV) estimate remaining at Rs960.

InvestingPro Insights

Adding to the optimistic outlook on DLF Ltd., recent data from InvestingPro provides further context to the company's financial position and market performance. Despite the weak pre-sales in Q2 FY2025, DLF's revenue growth remains strong, with a 22.23% increase over the last twelve months and an impressive 46.55% growth in the most recent quarter. This aligns with the management's confidence in meeting their pre-sales forecast for FY2025.

The company's profitability also appears solid, with a gross profit margin of 53.28% and an operating income margin of 26.4% over the last twelve months. These figures suggest that DLF maintains efficient operations despite market challenges.

InvestingPro Tips highlight that DLF has raised its dividend for 3 consecutive years and has maintained dividend payments for 18 consecutive years. This consistent dividend policy may appeal to income-focused investors, although the current dividend yield stands at a modest 0.64%.

While the stock has experienced a significant drop of 9.73% in the past week and 14.99% over the last month, it's worth noting that DLF has delivered a strong 45.75% return over the past year. This volatility could present opportunities for investors who share the analyst's bullish outlook.

For those seeking a more comprehensive analysis, InvestingPro offers 16 additional tips on DLF, providing a deeper understanding of the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.